{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:31:55Z","timestamp":1785807115747,"version":"3.56.0"},"reference-count":156,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R278-2018-804"],"award-info":[{"award-number":["R278-2018-804"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007405","name":"Danish Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sygeforsikringen Danmark","award":["2021-0245"],"award-info":[{"award-number":["2021-0245"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The escalating prevalence of dementia worldwide necessitates preventive strategies to mitigate its extensive health, psychological, and social impacts. As the prevalence of dementia continues to rise, gaining insights into its risk factors and causes becomes paramount, given the absence of a definitive cure. Cardiovascular disease has emerged as a prominent player in the complex landscape of dementia. Preventing dyslipidaemia, unhealthy western-type diets, hypertension, diabetes, being overweight, physical inactivity, smoking, and high alcohol intake have the potential to diminish not only cardiovascular disease but also dementia. The purpose of this review is to present our current understanding of cardiovascular risk factors for Alzheimer\u2019s disease and vascular dementia (VaD) by using clinical human data from observational, genetic studies and clinical trials, while elaborating on potential mechanisms. Hypertension and Type 2 diabetes surface as significant causal risk factors for both Alzheimer\u2019s disease and VaD, as consistently illustrated in observational and Mendelian randomization studies. Anti-hypertensive drugs and physical activity have been shown to improve cognitive function in clinical trials. Important to note is that robust genome-wide association studies are lacking for VaD, and indeed more and prolonged clinical trials are needed to establish these findings and investigate other risk factors. Trials should strategically target individuals at the highest dementia risk, identified using risk charts incorporating genetic markers, biomarkers, and cardiovascular risk factors. Understanding causal risk factors for dementia will optimize preventive measures, and the implementation of well-known therapeutics can halt or alleviate dementia symptoms if started early. Needless to mention is that future health policies should prioritize primordial prevention from early childhood to prevent risk factors from even occurring in the first place. Together, understanding the role of cardiovascular risk factors in dementia, improving genome-wide association studies for VaD, and advancing clinical trials are crucial steps in addressing this significant public health challenge.<\/jats:p>","DOI":"10.1093\/cvr\/cvae235","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T11:42:30Z","timestamp":1730806950000},"page":"537-549","source":"Crossref","is-referenced-by-count":26,"title":["Causal cardiovascular risk factors for dementia: insights from observational and genetic studies"],"prefix":"10.1093","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7112-9387","authenticated-orcid":false,"given":"Emilie Westerlin","family":"Kjeldsen","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2014Rigshospitalet , Blegdamsvej 9, 2100 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4084-5027","authenticated-orcid":false,"given":"Ruth","family":"Frikke-Schmidt","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2014Rigshospitalet , Blegdamsvej 9, 2100 Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , 2200 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"2025050612370559200_cvae235-B1","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1016\/j.jacc.2019.04.034","article-title":"Vascular cognitive impairment and dementia","volume":"73","author":"Iadecola","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2025050612370559200_cvae235-B2","author":"WHO"},{"key":"2025050612370559200_cvae235-B3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet standing commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"2025050612370559200_cvae235-B4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/STROKEAHA.121.032610","article-title":"Risk factors, lifestyle behaviors, and vascular brain health","volume":"53","author":"Gottesman","year":"2022","journal-title":"Stroke"},{"key":"2025050612370559200_cvae235-B5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MOL.0000000000000723","article-title":"Impact of metabolic dysfunction on cognition in humans","volume":"32","author":"Juul Rasmussen","year":"2021","journal-title":"Curr Opin Lipidol"},{"key":"2025050612370559200_cvae235-B6","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"2025050612370559200_cvae235-B7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"2025050612370559200_cvae235-B8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.conb.2019.11.024","article-title":"Genetics of Alzheimer\u2019s disease: where we are, and where we are going","volume":"61","author":"Bellenguez","year":"2020","journal-title":"Curr Opin Neurobiol"},{"key":"2025050612370559200_cvae235-B9","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025050612370559200_cvae235-B10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer\u2019s disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"2025050612370559200_cvae235-B11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-neuro-071013-014300","article-title":"Apolipoprotein E in Alzheimer\u2019s disease: an update","volume":"37","author":"Yu","year":"2014","journal-title":"Annu Rev Neurosci"},{"key":"2025050612370559200_cvae235-B12","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"key":"2025050612370559200_cvae235-B13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat Genet"},{"key":"2025050612370559200_cvae235-B14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat Genet"},{"key":"2025050612370559200_cvae235-B15","author":"GWAS Catalog"},{"key":"2025050612370559200_cvae235-B16","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1038\/s41380-023-02076-1","article-title":"Step by step: towards a better understanding of the genetic architecture of Alzheimer\u2019s disease","volume":"28","author":"Lambert","year":"2023","journal-title":"Mol Psychiatry"},{"key":"2025050612370559200_cvae235-B17","doi-asserted-by":"crossref","first-page":"104511","DOI":"10.1016\/j.ebiom.2023.104511","article-title":"The complex genetic architecture of Alzheimer\u2019s disease: novel insights and future directions","volume":"90","author":"Andrews","year":"2023","journal-title":"EBioMedicine"},{"key":"2025050612370559200_cvae235-B18","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1038\/s41467-021-22491-8","article-title":"Common variants in Alzheimer\u2019s disease and risk stratification by polygenic risk scores","volume":"12","author":"de Rojas","year":"2021","journal-title":"Nat Commun"},{"key":"2025050612370559200_cvae235-B19","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/eurheartj\/ehad293","article-title":"Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia","volume":"44","author":"Juul Rasmussen","year":"2023","journal-title":"Eur Heart J"},{"key":"2025050612370559200_cvae235-B20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2025050612370559200_cvae235-B21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"2025050612370559200_cvae235-B22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ana.21509","article-title":"Prodromal Alzheimer\u2019s disease: successive emergence of the clinical symptoms","volume":"64","author":"Amieva","year":"2008","journal-title":"Ann Neurol"},{"key":"2025050612370559200_cvae235-B23","author":"Alzheimer\u2019s Association Workgroup"},{"key":"2025050612370559200_cvae235-B24","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12213","article-title":"Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019","volume":"17","author":"Knopman","year":"2021","journal-title":"Alzheimers Dement"},{"key":"2025050612370559200_cvae235-B25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"2025050612370559200_cvae235-B26","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","article-title":"Trial of solanezumab in preclinical Alzheimer\u2019s disease","volume":"389","author":"Sperling","year":"2023","journal-title":"N Engl J Med"},{"key":"2025050612370559200_cvae235-B27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2017.09.007","article-title":"Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the vascular impairment of cognition classification consensus study","volume":"14","author":"Skrobot","year":"2018","journal-title":"Alzheimers Dement"},{"key":"2025050612370559200_cvae235-B28","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1002\/alz.14115","article-title":"A genome-wide association meta-analysis of all-cause and vascular dementia","volume":"20","author":"Mega Vascular Cognitive Impairment and Dementia (MEGAVCID) consortium","year":"2024","journal-title":"Alzheimers Dement"},{"key":"2025050612370559200_cvae235-B29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/CIRCRESAHA.116.308426","article-title":"Vascular cognitive impairment","volume":"120","author":"Dichgans","year":"2017","journal-title":"Circ Res"},{"key":"2025050612370559200_cvae235-B30","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","article-title":"Vascular dementia","volume":"386","author":"O\u2019Brien","year":"2015","journal-title":"Lancet"},{"key":"2025050612370559200_cvae235-B31","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"2025050612370559200_cvae235-B32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41569-020-00493-1","article-title":"Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development","volume":"18","author":"Holmes M","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2025050612370559200_cvae235-B33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamacardio.2023.4115","article-title":"Mendelian randomization as a tool for cardiovascular research","volume":"9","author":"Levin","year":"2024","journal-title":"JAMA Cardiol"},{"key":"2025050612370559200_cvae235-B34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41569-022-00676-y","article-title":"Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia","volume":"19","author":"Bor\u00e9n","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2025050612370559200_cvae235-B35","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur Heart J"},{"key":"2025050612370559200_cvae235-B36","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41569-021-00538-z","article-title":"High-density lipoproteins, reverse cholesterol transport and atherogenesis","volume":"18","author":"Pownall","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2025050612370559200_cvae235-B37","doi-asserted-by":"crossref","first-page":"159123","DOI":"10.1016\/j.bbalip.2022.159123","article-title":"Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders","volume":"1867","author":"Turri","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2025050612370559200_cvae235-B38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MOL.0000000000000291","article-title":"Relation between plasma and brain lipids","volume":"27","author":"Wellington","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"2025050612370559200_cvae235-B39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1124\/jpet.118.254201","article-title":"Apolipoprotein A-I crosses the blood-brain barrier through clathrin-independent and cholesterol-mediated endocytosis","volume":"369","author":"Zhou","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"2025050612370559200_cvae235-B40","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3389\/fphys.2017.00841","article-title":"SR-BI mediated transcytosis of HDL in brain microvascular endothelial cells is independent of Caveolin, Clathrin, and PDZK1","volume":"8","author":"Fung","year":"2017","journal-title":"Front Physiol"},{"key":"2025050612370559200_cvae235-B41","doi-asserted-by":"crossref","first-page":"e1002265","DOI":"10.1371\/journal.pmed.1002265","article-title":"Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C study: a longitudinal, population-based prospective cohort study.","volume":"14","author":"Schilling","year":"2017","journal-title":"PLoS Med"},{"key":"2025050612370559200_cvae235-B42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2014.07.015","article-title":"HDL and cognition in neurodegenerative disorders","volume":"72","author":"Hottman","year":"2014","journal-title":"Neurobiol Dis"},{"key":"2025050612370559200_cvae235-B43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3233\/JAD-160826","article-title":"Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis","volume":"56","author":"Anstey","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"2025050612370559200_cvae235-B44","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jalz.2017.11.012","article-title":"Circulating metabolites and general cognitive ability and dementia: evidence from 11 cohort studies","volume":"14","author":"van der Lee","year":"2018","journal-title":"Alzheimers Dement"},{"key":"2025050612370559200_cvae235-B45","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11357-016-9950-x","article-title":"Apolipoproteins and HDL cholesterol do not associate with the risk of future dementia and Alzheimer\u2019s disease: the National Finnish population study (FINRISK)","volume":"38","author":"Tynkkynen","year":"2016","journal-title":"Age (Dordr)"},{"key":"2025050612370559200_cvae235-B46","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jalz.2018.01.003","article-title":"Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer\u2019s disease: a prospective study in eight cohorts","volume":"14","author":"Tynkkynen","year":"2018","journal-title":"Alzheimers Dement"},{"key":"2025050612370559200_cvae235-B47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41398-018-0336-y","article-title":"The association between midlife serum high-density lipoprotein and mild cognitive impairment and dementia after 19 years of follow-up","volume":"9","author":"Svensson","year":"2019","journal-title":"Transl Psychiatry"},{"key":"2025050612370559200_cvae235-B48","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archneurol.2010.297","article-title":"Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease","volume":"67","author":"Reitz","year":"2010","journal-title":"Arch Neurol"},{"key":"2025050612370559200_cvae235-B49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13024-019-0353-1","article-title":"Longitudinal and nonlinear relations of dietary and serum cholesterol in midlife with cognitive decline: results from EMCOA study","volume":"14","author":"An","year":"2019","journal-title":"Mol Neurodegener"},{"key":"2025050612370559200_cvae235-B50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jalz.2017.07.757","article-title":"Association of midlife lipids with 20-year cognitive change: a cohort study","volume":"14","author":"Power","year":"2018","journal-title":"Alzheimers Dement"},{"key":"2025050612370559200_cvae235-B51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fnagi.2019.00370","article-title":"Revealing a novel landscape of the association between blood lipid levels and Alzheimer\u2019s disease: a meta-analysis of a case-control study","volume":"11","author":"Tang","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"2025050612370559200_cvae235-B52","doi-asserted-by":"crossref","first-page":"E2172","DOI":"10.1212\/WNL.0000000000207876","article-title":"Low- and high-density lipoprotein cholesterol and dementia risk over 17 years of follow-up among members of a large health care plan","volume":"101","author":"Ferguson","year":"2023","journal-title":"Neurology"},{"key":"2025050612370559200_cvae235-B53","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/cvr\/cvab164","article-title":"Plasma high-density lipoprotein cholesterol and risk of dementia: observational and genetic studies","volume":"118","author":"Kjeldsen","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2025050612370559200_cvae235-B54","doi-asserted-by":"crossref","first-page":"e1001841","DOI":"10.1371\/journal.pmed.1001841","article-title":"Associations between potentially modifiable risk factors and Alzheimer disease: a Mendelian randomization study","volume":"12","author":"\u00d8stergaard","year":"2015","journal-title":"PLoS Med"},{"key":"2025050612370559200_cvae235-B55","doi-asserted-by":"crossref","first-page":"21747","DOI":"10.18632\/aging.103983","article-title":"Detecting potential causal relationship between multiple risk factors and Alzheimer\u2019s disease using multivariable Mendelian randomization","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"2025050612370559200_cvae235-B56","doi-asserted-by":"crossref","first-page":"e1001713","DOI":"10.1371\/journal.pmed.1001713","article-title":"Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis","volume":"11","author":"Proitsi","year":"2014","journal-title":"PLoS Med"},{"key":"2025050612370559200_cvae235-B57","doi-asserted-by":"crossref","first-page":"e2313734","DOI":"10.1001\/jamanetworkopen.2023.13734","article-title":"Genetic associations between modifiable risk factors and Alzheimer disease","volume":"6","author":"Luo","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025050612370559200_cvae235-B58","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2004.02373.x","article-title":"Uptake and transport of high-density lipoprotein (HDL) and HDL-associated \u03b1-tocopherol by an in vitro blood-brain barrier model","volume":"89","author":"Balazs","year":"2004","journal-title":"J Neurochem"},{"key":"2025050612370559200_cvae235-B59","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/alz.12649","article-title":"The small HDL particle hypothesis of Alzheimer\u2019s disease","volume":"19","author":"Martinez","year":"2023","journal-title":"Alzheimers Dement"},{"key":"2025050612370559200_cvae235-B60","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"Zanoni","year":"2016","journal-title":"Science"},{"key":"2025050612370559200_cvae235-B61","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MOL.0000000000000294","article-title":"HDLs in crises","volume":"27","author":"Von Eckardstein","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"2025050612370559200_cvae235-B62","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"key":"2025050612370559200_cvae235-B63","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.3390\/nu13062118","article-title":"The role of high triglycerides level in predicting cognitive impairment: a review of current evidence","volume":"13","author":"Dimache","year":"2021","journal-title":"Nutrients"},{"key":"2025050612370559200_cvae235-B64","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/acn3.51516","article-title":"Lipid levels and the risk of dementia: a dose\u2013response meta-analysis of prospective cohort studies","volume":"9","author":"Zhu","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"2025050612370559200_cvae235-B65","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/clinchem\/hvaa269","article-title":"Triglycerides as a shared risk factor between dementia and atherosclerotic cardiovascular disease: a study of 125,727 individuals","volume":"67","author":"Nordestgaard","year":"2021","journal-title":"Clin Chem"},{"key":"2025050612370559200_cvae235-B66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2337\/dc08-0272","article-title":"Metabolic syndrome and risk for incident Alzheimer\u2019s disease or vascular dementia","volume":"32","author":"Raffaitin","year":"2009","journal-title":"Diabetes Care"},{"key":"2025050612370559200_cvae235-B67","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/01.ATV.20.10.2255","article-title":"Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men","volume":"20","author":"Kalmijn","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025050612370559200_cvae235-B68","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","article-title":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025050612370559200_cvae235-B69","first-page":"e12395","article-title":"The relationship between midlife dyslipidemia and lifetime incidence of dementia: a systematic review and meta-analysis of cohort studies","volume":"15","author":"Wee","year":"2023","journal-title":"Alzheimers Dement"},{"key":"2025050612370559200_cvae235-B70","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/eurjpc\/zwab208","article-title":"Statin use and risk of dementia or Alzheimer\u2019s disease: a systematic review and meta-analysis of observational studies","volume":"29","author":"Olmastroni","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2025050612370559200_cvae235-B71","first-page":"CD003160","article-title":"Statins for the prevention of dementia","volume":"2016","author":"McGuinness","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025050612370559200_cvae235-B72","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s10072-020-04243-6","article-title":"The efficacy of statins in the treatment of Alzheimer\u2019s disease: a meta-analysis of randomized controlled trial","volume":"41","author":"Xuan","year":"2020","journal-title":"Neurol Sci"},{"key":"2025050612370559200_cvae235-B73","doi-asserted-by":"crossref","first-page":"j1648","DOI":"10.1136\/bmj.j1648","article-title":"Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer\u2019s disease and Parkinson\u2019s disease: Mendelian randomisation study","volume":"357","author":"Benn","year":"2017","journal-title":"BMJ"},{"key":"2025050612370559200_cvae235-B74","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1212\/WNL.0000000000013120","article-title":"Cardiovascular risk factors and MRI markers of cerebral small vessel disease","volume":"98","author":"Taylor-Bateman","year":"2022","journal-title":"Neurology"},{"key":"2025050612370559200_cvae235-B75","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"2025050612370559200_cvae235-B76","doi-asserted-by":"crossref","first-page":"e501","DOI":"10.1016\/S2666-7568(22)00120-9","article-title":"Nutrition state of science and dementia prevention: recommendations of the Nutrition for Dementia Prevention Working Group","volume":"3","author":"Yassine","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"2025050612370559200_cvae235-B77","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"2025050612370559200_cvae235-B78","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/advances\/nmaa053","article-title":"Dietary factors and neurodegenerative disorders: an umbrella review of meta-analyses of prospective studies","volume":"11","author":"Barbaresko","year":"2020","journal-title":"Adv Nutr"},{"key":"2025050612370559200_cvae235-B79","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/advances\/nmz054","article-title":"The Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diets are associated with less cognitive decline and a lower risk of Alzheimer\u2019s disease\u2014a review","volume":"10","author":"Van Den Brink","year":"2019","journal-title":"Adv Nutr"},{"key":"2025050612370559200_cvae235-B80","first-page":"1","article-title":"The impact of the Mediterranean diet on the cognitive functioning of healthy older adults: a systematic review and meta-analysis","volume":"6","author":"Kelly","year":"2017","journal-title":"Adv Nutr"},{"key":"2025050612370559200_cvae235-B81","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/ajcn\/nqx070","article-title":"Effect of the Mediterranean diet on cognition and brain morphology and function: a systematic review of randomized controlled trials","volume":"107","author":"Radd-Vagenas","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"2025050612370559200_cvae235-B82","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1056\/NEJMoa2302368","article-title":"Trial of the MIND diet for prevention of cognitive decline in older persons","volume":"389","author":"Barnes","year":"2023","journal-title":"N Engl J Med"},{"key":"2025050612370559200_cvae235-B83","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1017\/S2045796022000567","article-title":"Adherence to dietary guidelines and risk of dementia: a prospective cohort study of 94 184 individuals","volume":"31","author":"Kjeldsen","year":"2022","journal-title":"Epidemiol Psychiatr Sci"},{"key":"2025050612370559200_cvae235-B84","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12603-012-0042-z","article-title":"Nutrition and vascular dementia","volume":"16","author":"Perez","year":"2012","journal-title":"J Nutr Health Aging"},{"key":"2025050612370559200_cvae235-B85","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3945\/ajcn.112.045575","article-title":"Dietary patterns and risk of dementia in an elderly Japanese population: the Hisayama study1-3","volume":"97","author":"Ozawa","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"2025050612370559200_cvae235-B86","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3233\/JAD-215535","article-title":"Causal relationships between relative intake from the macronutrients and Alzheimer\u2019s disease: a two-sample Mendelian randomization study","volume":"87","author":"Wang","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"2025050612370559200_cvae235-B87","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.3390\/nu13082893","article-title":"Genetically predicted milk intake and risk of neurodegenerative diseases","volume":"13","author":"Zhang","year":"2021","journal-title":"Nutrients"},{"key":"2025050612370559200_cvae235-B88","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"2025050612370559200_cvae235-B89","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/alz.12320","article-title":"Midlife vascular risk factors and risk of incident dementia: longitudinal cohort and Mendelian randomization analyses in the UK Biobank","volume":"17","author":"Malik","year":"2021","journal-title":"Alzheimers Dement"},{"key":"2025050612370559200_cvae235-B90","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-190474","article-title":"Midlife hypertension and Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"71","author":"Lennon","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"2025050612370559200_cvae235-B91","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/S0140-6736(19)30041-8","article-title":"Health effects of dietary risks in 195 countries, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"393","author":"Afshin","year":"2019","journal-title":"Lancet"},{"key":"2025050612370559200_cvae235-B92","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(22)00122-2","article-title":"Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial","volume":"399","author":"Delgado-Lista","year":"2022","journal-title":"Lancet"},{"key":"2025050612370559200_cvae235-B93","doi-asserted-by":"crossref","first-page":"100419","DOI":"10.1016\/j.lanepe.2022.100419","article-title":"Impact of diet on ten-year absolute cardiovascular risk in a prospective cohort of 94 321 individuals: a tool for implementation of healthy diets","volume":"19","author":"Kjeldsen","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2025050612370559200_cvae235-B94","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1093\/eurheartj\/ehad211","article-title":"Vegetarian or vegan diets and blood lipids: a meta-analysis of randomized trials","volume":"44","author":"Koch","year":"2023","journal-title":"Eur Heart J"},{"key":"2025050612370559200_cvae235-B95","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/HYPERTENSIONAHA.120.14993","article-title":"Blood pressure and risks of cognitive impairment and dementia","volume":"76","author":"Ou","year":"2020","journal-title":"Hypertension"},{"key":"2025050612370559200_cvae235-B96","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/jnnp-2019-321913","article-title":"Evidence-based prevention of Alzheimer\u2019s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials","volume":"91","author":"Yu","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025050612370559200_cvae235-B97","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/gps.2572","article-title":"Hypertension is a potential risk factor for vascular dementia: systematic review","volume":"26","author":"Sharp","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"2025050612370559200_cvae235-B98","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1474-4422(19)30393-X","article-title":"Antihypertensive medications and risk for incident dementia and Alzheimer\u2019s disease: a meta-analysis of individual participant data from prospective cohort studies","volume":"19","author":"Ding","year":"2020","journal-title":"Lancet Neurol"},{"key":"2025050612370559200_cvae235-B99","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/HJH.0000000000000868","article-title":"Diuretic antihypertensive drugs and incident dementia risk","volume":"34","author":"Tully","year":"2016","journal-title":"J Hypertens"},{"key":"2025050612370559200_cvae235-B100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2018.02.027","article-title":"Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients: a meta-analysis of prospective studies","volume":"671","author":"Hussain","year":"2018","journal-title":"Neurosci Lett"},{"key":"2025050612370559200_cvae235-B101","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2020.4249","article-title":"Association of blood pressure lowering with incident dementia or cognitive impairment","volume":"323","author":"Hughes","year":"2020","journal-title":"JAMA"},{"key":"2025050612370559200_cvae235-B102","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13195-017-0262-x","article-title":"Association between blood pressure and Alzheimer disease measured up to 27 years prior to diagnosis: the HUNT study","volume":"9","author":"Gabin","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"2025050612370559200_cvae235-B103","doi-asserted-by":"crossref","first-page":"j5375","DOI":"10.1136\/bmj.j5375","article-title":"Modifiable pathways in Alzheimer\u2019s disease: Mendelian randomisation analysis","volume":"359","author":"Larsson","year":"2017","journal-title":"BMJ"},{"key":"2025050612370559200_cvae235-B104","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.biopsych.2020.12.015","article-title":"High blood pressure and risk of dementia: a two-sample Mendelian randomization study in the UK Biobank","volume":"89","author":"Sproviero","year":"2021","journal-title":"Biol Psychiatry"},{"key":"2025050612370559200_cvae235-B105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/HYPERTENSIONAHA.114.04257","article-title":"Hypertension and Alzheimer disease","volume":"65","author":"Thorin","year":"2015","journal-title":"Hypertension"},{"key":"2025050612370559200_cvae235-B106","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11906-017-0724-3","article-title":"Defining the relationship between hypertension, cognitive decline, and dementia: a review","volume":"19","author":"Walker","year":"2017","journal-title":"Curr Hypertens Rep"},{"key":"2025050612370559200_cvae235-B107","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1177\/0271678X18803374","article-title":"Hypertension, dietary salt and cognitive impairment","volume":"38","author":"Santisteban","year":"2018","journal-title":"J Cereb Blood Flow Metab"},{"key":"2025050612370559200_cvae235-B108","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"2025050612370559200_cvae235-B109","doi-asserted-by":"crossref","first-page":"e062415","DOI":"10.1002\/alz.062415","article-title":"Evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating the neuroprotective effects of semaglutide in early Alzheimer\u2019s disease","volume":"18","author":"Atri","year":"2022","journal-title":"Alzheimers Dement Poster"},{"key":"2025050612370559200_cvae235-B110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2337\/dc15-1588","article-title":"Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia","volume":"39","author":"Chatterjee","year":"2016","journal-title":"Diabetes Care"},{"key":"2025050612370559200_cvae235-B111","doi-asserted-by":"crossref","first-page":"100944","DOI":"10.1016\/j.arr.2019.100944","article-title":"Diabetes mellitus and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 144 prospective studies","volume":"55","author":"Xue","year":"2019","journal-title":"Ageing Res Rev"},{"key":"2025050612370559200_cvae235-B112","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1017\/S2045796020000347","article-title":"Type-2 diabetes and risk of dementia: observational and Mendelian randomisation studies in 1 million individuals","volume":"29","author":"Thomassen","year":"2020","journal-title":"Epidemiol Psychiatr Sci"},{"key":"2025050612370559200_cvae235-B113","doi-asserted-by":"crossref","first-page":"154265","DOI":"10.1016\/j.metabol.2020.154265","article-title":"Impact of antidiabetic agents on dementia risk: a Bayesian network meta-analysis","volume":"109","author":"Zhou","year":"2020","journal-title":"Metabolism"},{"key":"2025050612370559200_cvae235-B114","first-page":"e12268","article-title":"Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers","volume":"8","author":"N\u00f8rgaard","year":"2022","journal-title":"Alzheimers Dement"},{"key":"2025050612370559200_cvae235-B115","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00125-020-05124-5","article-title":"Impact of glucose on risk of dementia: Mendelian randomisation studies in 115,875 individuals","volume":"63","author":"Benn","year":"2020","journal-title":"Diabetologia"},{"key":"2025050612370559200_cvae235-B116","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.2337\/db20-0895","article-title":"Relationship between glycemia and cognitive function, structural brain outcomes, and dementia: a Mendelian randomization study in the UK Biobank","volume":"70","author":"Garfield","year":"2021","journal-title":"Diabetes"},{"key":"2025050612370559200_cvae235-B117","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s00125-022-05743-0","article-title":"Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer\u2019s disease risk in the general population: a Mendelian randomisation study","volume":"65","author":"Zheng","year":"2022","journal-title":"Diabetologia"},{"key":"2025050612370559200_cvae235-B118","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1212\/WNL.0000000000200771","article-title":"Genetic variation in targets of antidiabetic drugs and Alzheimer disease risk","volume":"99","author":"Tang","year":"2022","journal-title":"Neurology"},{"key":"2025050612370559200_cvae235-B119","first-page":"22688","article-title":"Glycemic traits and Alzheimer\u2019s disease: a Mendelian randomization study","volume":"12","author":"Pan","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"2025050612370559200_cvae235-B120","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1002\/alz.13373","article-title":"Mendelian randomization study of diabetes and dementia in the million veteran program","volume":"19","author":"Litkowski","year":"2023","journal-title":"Alzheimers Dement"},{"key":"2025050612370559200_cvae235-B121","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1210\/jc.2017-01922","article-title":"Diabetic microvascular disease: an endocrine society scientific statement","volume":"102","author":"Barrett","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025050612370559200_cvae235-B122","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.3390\/ijms23052687","article-title":"Alzheimer\u2019s disease as type 3 diabetes: common pathophysiological mechanisms between Alzheimer\u2019s disease and type 2 diabetes","volume":"23","author":"Michailidis","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025050612370559200_cvae235-B123","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action","volume":"20","author":"Ussher","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"2025050612370559200_cvae235-B124","doi-asserted-by":"crossref","first-page":"e076410","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"2025050612370559200_cvae235-B125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/1028415X.2020.1758888","article-title":"Body mass index and risk of Parkinson, Alzheimer, dementia, and dementia mortality: a systematic review and dose\u2013response meta-analysis of cohort studies among 5 million participants","volume":"25","author":"Rahmani","year":"2022","journal-title":"Nutr Neurosci"},{"key":"2025050612370559200_cvae235-B126","doi-asserted-by":"crossref","first-page":"e12989","DOI":"10.1111\/obr.12989","article-title":"Association of anthropometry and weight change with risk of dementia and its major subtypes: a meta-analysis consisting 2.8 million adults with 57 294 cases of dementia","volume":"21","author":"Lee","year":"2020","journal-title":"Obes Rev"},{"key":"2025050612370559200_cvae235-B127","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ageing\/afv151","article-title":"The risk of overweight\/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies","volume":"45","author":"Pedditizi","year":"2016","journal-title":"Age Ageing"},{"key":"2025050612370559200_cvae235-B128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neubiorev.2021.08.028","article-title":"Relationship between central obesity and the incidence of cognitive impairment and dementia from cohort studies involving 5,060,687 participants","volume":"130","author":"Tang","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"2025050612370559200_cvae235-B129","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1210\/jc.2017-00195","article-title":"Body mass index and risk of Alzheimer\u2019s disease: a Mendelian randomization study of 399,536 individuals","volume":"102","author":"Nordestgaard","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025050612370559200_cvae235-B130","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jalz.2015.05.015","article-title":"Genetically predicted body mass index and Alzheimer\u2019s disease\u2013related phenotypes in three large samples: Mendelian randomization analyses","volume":"11","author":"Mukherjee","year":"2015","journal-title":"Alzheimers Dement"},{"key":"2025050612370559200_cvae235-B131","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12916-021-02188-x","article-title":"Causal role of high body mass index in multiple chronic diseases: a systematic review and meta-analysis of Mendelian randomization studies","volume":"19","author":"Larsson","year":"2021","journal-title":"BMC Med"},{"key":"2025050612370559200_cvae235-B132","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1093\/aje\/kwab103","article-title":"Extension of Mendelian randomization to identify earliest manifestations of Alzheimer disease: association of genetic risk score for Alzheimer disease with lower body mass index by age 50 years","volume":"190","author":"Brenowitz","year":"2021","journal-title":"Am J Epidemiol"},{"key":"2025050612370559200_cvae235-B133","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ana.25686","article-title":"Mendelian randomization study of obesity and cerebrovascular disease","volume":"87","author":"Marini","year":"2020","journal-title":"Ann Neurol"},{"key":"2025050612370559200_cvae235-B134","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/bjsports-2021-104981","article-title":"Physical activity as a protective factor for dementia and Alzheimer\u2019s disease: systematic review, meta-analysis and quality assessment of cohort and case-control studies","volume":"56","author":"Iso-Markku","year":"2022","journal-title":"Br J Sports Med"},{"key":"2025050612370559200_cvae235-B135","doi-asserted-by":"crossref","first-page":"e014706","DOI":"10.1136\/bmjopen-2016-014706","article-title":"Leisure time physical activity and dementia risk: a dose-response meta-analysis of prospective studies","volume":"7","author":"Xu","year":"2017","journal-title":"BMJ Open"},{"key":"2025050612370559200_cvae235-B136","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2022.08.004","article-title":"Physical activity in leisure time and at work and risk of dementia: a prospective cohort study of 117,616 individuals","volume":"360","author":"Juul Rasmussen","year":"2022","journal-title":"Atherosclerosis"},{"key":"2025050612370559200_cvae235-B137","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.arr.2015.11.005","article-title":"The effect of physical activity on cognitive function in patients with dementia: a meta-analysis of randomized control trials","volume":"25","author":"Groot","year":"2016","journal-title":"Ageing Res Rev"},{"key":"2025050612370559200_cvae235-B138","doi-asserted-by":"crossref","first-page":"12976","DOI":"10.1038\/s41598-022-17207-x","article-title":"Using a two-sample Mendelian randomization analysis to explore the relationship between physical activity and Alzheimer\u2019s disease","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci Rep"},{"key":"2025050612370559200_cvae235-B139","doi-asserted-by":"crossref","first-page":"e1897","DOI":"10.1212\/WNL.0000000000010013","article-title":"Physical activity and risk of Alzheimer disease","volume":"95","author":"Baumeister","year":"2020","journal-title":"Neurology"},{"key":"2025050612370559200_cvae235-B140","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.3390\/ijms22062897","article-title":"Physical exercise and Alzheimer\u2019s disease: effects on pathophysiological molecular pathways of the disease","volume":"22","author":"L\u00f3pez-Ortiz","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025050612370559200_cvae235-B141","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jad.2022.07.008","article-title":"Modifiable risk factors for incident dementia and cognitive impairment: an umbrella review of evidence","volume":"314","author":"Zhang","year":"2022","journal-title":"J Affect Disord"},{"key":"2025050612370559200_cvae235-B142","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/aje\/kwm116","article-title":"Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies","volume":"166","author":"Anstey","year":"2007","journal-title":"Am J Epidemiol"},{"key":"2025050612370559200_cvae235-B143","doi-asserted-by":"crossref","first-page":"e0118333","DOI":"10.1371\/journal.pone.0118333","article-title":"Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers.","volume":"10","author":"Zhong","year":"2015","journal-title":"PLoS One"},{"key":"2025050612370559200_cvae235-B144","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2022.03.022","article-title":"Self-reported and genetically predicted coffee consumption and smoking in dementia: a Mendelian randomization study","volume":"348","author":"Nordestgaard","year":"2022","journal-title":"Atherosclerosis"},{"key":"2025050612370559200_cvae235-B145","doi-asserted-by":"crossref","first-page":"104154","DOI":"10.1016\/j.ebiom.2022.104154","article-title":"Appraising the causal role of smoking in multiple diseases: a systematic review and meta-analysis of Mendelian randomization studies","volume":"82","author":"Larsson","year":"2022","journal-title":"EBioMedicine"},{"key":"2025050612370559200_cvae235-B146","volume-title":"Tobacco Knowledge Summaries: Tobacco & Dementia","author":"McKenzie","year":"2014"},{"key":"2025050612370559200_cvae235-B147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0453-0","article-title":"Alcohol use and dementia: a systematic scoping review","volume":"11","author":"Rehm","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"2025050612370559200_cvae235-B148","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/JGP.0b013e3181a2fd07","article-title":"Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies","volume":"17","author":"Anstey","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"key":"2025050612370559200_cvae235-B149","doi-asserted-by":"crossref","first-page":"k2927","DOI":"10.1136\/bmj.k2927","article-title":"Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study","volume":"362","author":"Sabia","year":"2018","journal-title":"BMJ"},{"key":"2025050612370559200_cvae235-B150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10654-017-0225-3","article-title":"Alcohol consumption and dementia risk: a dose\u2013response meta-analysis of prospective studies","volume":"32","author":"Xu","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"2025050612370559200_cvae235-B151","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jalz.2019.09.086","article-title":"Association between alcohol consumption and Alzheimer\u2019s disease: a Mendelian randomization study","volume":"16","author":"Andrews","year":"2020","journal-title":"Alzheimers Dement"},{"key":"2025050612370559200_cvae235-B152","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(16)30950-3","article-title":"Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial","volume":"388","author":"van Charante","year":"2016","journal-title":"Lancet"},{"key":"2025050612370559200_cvae235-B153","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","article-title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial","volume":"385","author":"Ngandu","year":"2015","journal-title":"Lancet"},{"key":"2025050612370559200_cvae235-B154","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2017.09.006","article-title":"Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: the FINGER trial","volume":"14","author":"Rosenberg","year":"2018","journal-title":"Alzheimers Dement"},{"key":"2025050612370559200_cvae235-B155","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","article-title":"Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial","volume":"16","author":"Andrieu","year":"2017","journal-title":"Lancet Neurol"},{"key":"2025050612370559200_cvae235-B156","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1093\/eurheartj\/ehaa695","article-title":"Impact of cardiovascular risk factors and genetics on 10-year absolute risk of dementia: risk charts for targeted prevention","volume":"41","author":"Juul Rasmussen","year":"2020","journal-title":"Eur Heart J"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvae235\/60762473\/cvae235.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/121\/4\/537\/60762473\/cvae235.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/121\/4\/537\/60762473\/cvae235.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T16:37:45Z","timestamp":1746549465000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/121\/4\/537\/7876119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":156,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,11,5]]},"published-print":{"date-parts":[[2025,5,6]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvae235","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,11,5]]}}}